Technical Analysis for DMTK - DermTech, Inc.

Grade Last Price % Change Price Change
F 0.69 -2.64% -0.02
DMTK closed up 9.08 percent on Wednesday, March 27, 2024, on 1.27 times normal volume.
3 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Up

Date Alert Name Type % Chg
Pocket Pivot Bullish Swing Setup -2.64%
Wide Bands Range Expansion -2.64%
New 52 Week Closing Low Bearish 6.20%
New 52 Week Low Weakness 6.20%
Wide Bands Range Expansion 6.20%
Down 3 Days in a Row Weakness 6.20%
Oversold Stochastic Weakness 6.20%
Wide Bands Range Expansion 4.59%
Oversold Stochastic Weakness 4.59%
Wide Bands Range Expansion 1.13%

   Recent Intraday Alerts

Alert Time
60 Minute Opening Range Breakout about 1 hour ago
10 DMA Support about 1 hour ago
60 Minute Opening Range Breakdown about 1 hour ago
Down 5% about 1 hour ago
Down 3% about 2 hours ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

DermTech, Inc. Description

DermTech, Inc., a molecular diagnostic company, develops and markets novel non-invasive diagnostic tests to diagnosis skin cancer and related conditions in the United States. The company offers Pigmented Lesion Assay (PLA), a gene expression test that helps rule out melanoma and the need for a surgical biopsy of atypical pigmented lesions. It also provides Nevome test, an adjunctive reflex test for the PLA; and adhesive skin sample collection kits, as well as gene expression assays for the Th1, Th2, IFN-gamma, and Th17 inflammatory pathways. The company is also developing non-melanoma skin cancer diagnostic and non-melanoma skin cancer risk assessment products. The company sells its products primarily to pathology and oncology practitioners. DermTech, Inc. is headquartered in La Jolla, California.


Classification

Sector: Industrials
Industry: Conglomerates
Keywords: Medicine Cancer Melanoma Dermatology Gene Expression Diagnostic Tests Risk Assessment Pathology Biopsy Skin Cancer Assessment Products Melanoma Skin Cancer Pigmented Lesion Cutaneous Conditions Non Melanoma Skin Cancer

Is DMTK a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 4.66
52 Week Low 0.6229
Average Volume 340,643
200-Day Moving Average 1.77
50-Day Moving Average 1.06
20-Day Moving Average 0.74
10-Day Moving Average 0.68
Average True Range 0.08
RSI (14) 35.90
ADX 37.6
+DI 13.29
-DI 28.55
Chandelier Exit (Long, 3 ATRs) 1.16
Chandelier Exit (Short, 3 ATRs) 0.86
Upper Bollinger Bands 1.03
Lower Bollinger Band 0.46
Percent B (%b) 0.44
BandWidth 75.97
MACD Line -0.13
MACD Signal Line -0.14
MACD Histogram 0.0162
Fundamentals Value
Market Cap 24.28 Million
Num Shares 34.2 Million
EPS -3.48
Price-to-Earnings (P/E) Ratio -0.20
Price-to-Sales 2.98
Price-to-Book 0.57
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.83
Resistance 3 (R3) 0.81 0.76 0.81
Resistance 2 (R2) 0.76 0.73 0.77 0.80
Resistance 1 (R1) 0.74 0.71 0.75 0.75 0.79
Pivot Point 0.68 0.68 0.69 0.69 0.68
Support 1 (S1) 0.66 0.65 0.67 0.67 0.62
Support 2 (S2) 0.61 0.63 0.61 0.62
Support 3 (S3) 0.58 0.61 0.61
Support 4 (S4) 0.59